Overcoming the response plateau in multiple myeloma: A novel bortezomib-based strategy for secondary induction and high-yield CD34+ stem cell mobilization

PURPOSE: This phase 2 study evaluated bortezomib-based secondary induction and stem cell mobilization in 38 transplant-eligible myeloma patients who had an incomplete and stalled response to, or had relapsed after, previous immunomodulatory drug-based induction. EXPERIMENTAL DESIGN: Patients receive...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Niesvizky, Ruben, Mark, Tomer M., Ward, Maureen, Jayabalan, David S., Pearse, Roger N., Manco, Megan, Stern, Jessica, Christos, Paul J., Mathews, Lena, Shore, Tsiporah B., Zafar, Faiza, Pekle, Karen, Xiang, Zhaoying, Ely, Scott, Skerret, Donna, Chen-Kiang, Selina, Coleman, Morton, Lane, Maureen E.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2013
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4020015/
https://ncbi.nlm.nih.gov/pubmed/23357980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-12-1429
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky